Log In
Print this Print this

OS342 (formerly NX101)

  Manage Alerts
Collapse Summary General Information
Company OncoSynergy Inc.
DescriptionRepurposed undisclosed molecule for intratumoral injection
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationNeurofibromatosis
Indication DetailsTreat neurofibromatosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today